1 points
QUESTION 9
1. It is important for the PMHNP to recognize differences in pharmacokinetics to safely
prescribe and monitor medications. Which
... [Show More] of the following statements does the competent PMHNP identify as true?
A About 1 out of 5 Asians requires lower-than-normal doses of some antidepressants
. and antipsychotics.
B The term polymorphic refers to the body’s ability to break a medication down several
. ways, and this patient may require higher doses of certain antidepressants and antipsychotics.
C About 1 out of 30 Caucasians requires lower doses of some antidepressants and
. antipsychotics.
D Most enzyme pathways do not have interactions between the newer medications.
.
1 points
QUESTION 10
1. As it relates to G-protein linked receptors, what does the PMHNP understand about medications that are used in practice?
A Most medications that act on G-protein linked receptors have antagonistic traits.
.
B The majority of medications used in practice are full agonists and are used to
. stimulate the body’s natural neurotransmitters.
C Most medications act as partial agonists because they allow the body to use only
. what is needed.
D Medications used in practice may act as inverse agonists if the dosage is too high.
.
1 points
QUESTION 11
1. The PMHNP is considering prescribing a 49-year-old male clozapine (Clozaril) to treat
his schizophrenia and suicidal ideations. The PMHNP is aware that which factor may impact the dose needed to effectively treat his condition:
A The patient smokes cigarettes.
.
B The patient has hypertension.
.
C The patient has chronic kidney
. disease, stage 2.
D The patient drinks a cup of coffee a
. day.
1 points
QUESTION 12
1. A patient is diagnosed with bipolar disorder and is currently taking carbamazepine (Tegretol), aripiprazole (Abilify), and melatonin. The PMHNP has just written an order to discontinue the carbamazepine (Tegretol) for drug-induced thrombocytopenia. The PMHNP
is aware that his next best action is to:
A Alert staff to possible seizures
.
B Write an order for a different mood stabilizer
.
C Decrease the amount prescribed for aripiprazole
. (Abilify)
D Explain to the patient that it will be more difficult to
. control his temper
1 points
QUESTION 13
1. A patient recently transferred following a suicide attempt has a history of schizophrenia, depression, and fibromyalgia. He is currently taking Amitriptyline (Elavil), Lisinopril, aspirin, and fluoxetine (Prozac). When assessing the psychiatric medications and the
reason for admission, what would be the best course of action for the PMHNP with this client?
A Review Amitriptyline (Elavil) level
.
B Order a STAT BUN/SCr
.
C Asses the client for nystagmus
.
D Order a STAT platelet, D-dimer, and PT/INR
.
1 points
QUESTION 14
1. A patient with schizophrenia is given an inverse agonist that acts on the receptor 5HT
and neurotransmitter serotonin. What is the rationale for prescribing a medication such as this?
A To promote the availability of serotonin
.
B To decrease serotonin
.
C To indirectly increase the amount of dopamine
. in the body
D To help decrease the amount of serotonin and
. dopamine
1 points
QUESTION 15
1. The PMHNP is caring for four patients. Which patient statement indicates that benzodiazepines would be beneficial?
A “I have trouble staying asleep in the middle of the night.”
.
B “My spouse told me that I seem to have trouble remembering
. things sometimes.”
C “I really want to stop smoking, but the cravings are too strong.”
.
D “I feel nervous to go outside and be in large crowds.”
.
1 points
QUESTION 16
1. Ms. Harlow is a 42-year-old patient who is prescribed a drug that acts on ionotropic receptors. She is curious about the effects of the drug and how it will act on her symptoms.
Which statement made by the PMHNP demonstrates proper understanding of Ms. Harlow’s prescription?
A “The drug will have an almost immediate
. effect.”
B “The drug can take a while to build up in your
. system.”
C “The drug is slow to release but lasts for a long
. time.”
D “The drug will make a subtle difference in your
. symptoms.”
1 points
QUESTION 17
1. A patient is seeking pharmacological treatment for smoking cessation. Which drug class does the PMHNP prescribe to the patient?
A Benzodiazepine
.
B Mirtazapine
. (Remeron)
C Ketamine
.
D Varenicline
. (Chantix)
1 points
QUESTION 18
1. The PMHNP is caring for a new patient who has been transferred from another office. When meeting with the new patient, the patient reports, “I feel like I am improving with the stabilizers.” The PMHNP immediately recognizes that the patient is describing which kind of
drug?
A Full agonists
.
B Antagonists
.
C Partial
. agonists
D Inverse
. agonists
1 points
QUESTION 19
1. A patient presents with frequent episodes of mania. Which statement describes an appropriate treatment approach for this patient?
A “The patient needs to have an inverse agonist.”
.
B “The patient could benefit from an anticonvulsant.”
.
C “The patient’s calcium, sodium, chloride, and potassium levels
. must be regulated.”
D “The patient should have a drug that acts on ligand-gated ion
. channels.”
1 points
QUESTION 20
1. What characteristics do the nicotinic, cholinergic, serotonin 3, and glycine receptors all have in common?
A Ligand-gated ion channels with a
. pentameric structure
B Ligand-gated ion channels with a
. tetrameric structure
C Voltage-sensitive ion channels
.
D Are G-coupled protein receptors
.
1 points
QUESTION 21
A “It’s my fault that all of this is happening. I don’t think I could ever
. forgive myself.”
B “I have to talk to the President because I’m the only one who can
. help him.”
C “I’m not sure why that lady is wearing a red jacket since it’s the dogs
. who need food.”
D “I don’t know that I even want to go to that meeting. It doesn’t seem
. worth it anymore.”
1 points
QUESTION 22
1. Mr. McCullin is 64 years old with Parkinson’s disease. The PMHNP caring for Mr. McCullin wants to start him on a dopamine agonist to help manage and treat his condition.
The PHMNP selects this agent because of which action it has on patients like Mr. McCullin?
A Dopamine is terminated through multiple mechanisms.
.
B The D2 autoreceptor regulates release of dopamine from the
. presynaptic neuron.
C MAO-B presents in the mitochondria within the presynaptic
. neuron.
D D2 receptors are the primary binding site for dopamine
. agonists.
1 points
QUESTION 23
1. Mrs. Trevor is a 44-year-old patient who does not have a diagnosis of schizophrenia but occasionally reports symptoms of psychosis, followed by severe fatigue. Mrs. Trevor
inquires about the use of amphetamines to help with her energy levels. Which response made by the PMHNP is most appropriate?
A “Amphetamines may help you, as they can alleviate psychotic conditions.”
.
B “Amphetamines can inhibit negative symptoms of schizophrenia, so this might be a
. good choice for you.”
C “Amphetamines can cause hallucinations, so I would advise against this type of
. prescription.”
D “Amphetamines can lead to a dopamine deficiency, so I will not prescribe this for
. you.”
1 points
QUESTION 24
A Blocking the release of dopamine facilitates the onset of positive schizophrenia
. symptoms.
B Hyperactivity in the mesolimbic dopamine pathway mediates the positive
. symptoms of schizophrenia.
C Antipsychotic drugs that open D2 receptor pathways can treat schizophrenia.
.
D The neuroanatomy of dopamine neuronal pathways can explain symptoms of
. schizophrenia.
1 points
QUESTION 25
1. A patient is diagnosed with schizophrenia. What increases the patient’s potential to mediate the cognitive symptoms of the disease?
A Achieving underactivity of the mesocorticol projections to the prefrontal
. cortex
B Achieving overactivity of the mesocorticol projections to the ventromedial
. prefrontal cortex
C Achieving underactivity of the mesocortical projections to the
. ventromedial prefrontal cortex
D Achieving overactivity of the mesocorticol projections to the prefrontal
. cortex
1 points [Show Less]